ADS · CUSIP 09075V102 · who reports it, how much, and how much it matters to them
21 of the 720 hedge fund managers we track reported shares of BioNTech SE (Nasdaq: BNTX) on Form 13F for 30 June 2026. Between them they reported USD 393m. The largest position belongs to Logos Global Management, at USD 94m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Logos Global Management1 fund on PPLI.com | USD 94m | 4.1% |
| 2 | Balyasny Asset Management25 funds on PPLI.com | USD 43m | 0.1% |
| 3 | D. E. Shaw & Co.15 funds on PPLI.com | USD 39m | 0.0% |
| 4 | Marshall Wace LLP84 funds on PPLI.com | USD 36m | 0.0% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 34m | 0.0% |
| 6 | POINT72 Asset Management17 funds on PPLI.com | USD 30m | 0.0% |
| 7 | Two Sigma Investments35 funds on PPLI.com | USD 27m | 0.0% |
| 8 | Hudson Bay Capital Management8 funds on PPLI.com | USD 24m | 0.1% |
| 9 | Voloridge Investment Management6 funds on PPLI.com | USD 23m | 0.1% |
| 10 | Squarepoint Ops7 funds on PPLI.com | USD 19m | 0.0% |
| 11 | Baker Bros. Advisors2 funds on PPLI.com | USD 11m | 0.1% |
| 12 | Walleye Capital8 funds on PPLI.com | USD 2.9m | 0.0% |
| 13 | Aquatic Capital Management3 funds on PPLI.com | USD 2.4m | 0.1% |
| 14 | Palo Alto Investors6 funds on PPLI.com | USD 1.8m | 0.3% |
| 15 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 1.8m | 0.1% |
| 16 | Engineers Gate Manager1 fund on PPLI.com | USD 1.2m | 0.0% |
| 17 | Aristides Capital2 funds on PPLI.com | USD 1m | 0.2% |
| 18 | Dafna Capital Management6 funds on PPLI.com | USD 651,000 | 0.1% |
| 19 | Verition Fund Management3 funds on PPLI.com | USD 433,000 | 0.0% |
| 20 | Persistent Asset Partners10 funds on PPLI.com | USD 256,000 | 0.1% |
| 21 | The Quarry1 fund on PPLI.com | USD 2,512 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Logos Global Management | USD 94m | 4.1% |
| 2 | Palo Alto Investors | USD 1.8m | 0.3% |
| 3 | Aristides Capital | USD 1m | 0.2% |
| 4 | Dafna Capital Management | USD 651,000 | 0.1% |
| 5 | Voloridge Investment Management | USD 23m | 0.1% |
| 6 | Campbell & Company Investment Adviser | USD 1.8m | 0.1% |
| 7 | Aquatic Capital Management | USD 2.4m | 0.1% |
| 8 | Persistent Asset Partners | USD 256,000 | 0.1% |
| 9 | Hudson Bay Capital Management | USD 24m | 0.1% |
| 10 | Baker Bros. Advisors | USD 11m | 0.1% |
BioNTech SE trades under the symbol BNTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 09075V102.
21 of the 720 hedge fund managers PPLI.com tracks reported BioNTech SE shares on Form 13F for 30 June 2026. The largest reported positions were held by Logos Global Management (USD 94m), Balyasny Asset Management (USD 43m), D. E. Shaw & Co. (USD 39m), Marshall Wace LLP (USD 36m) and Citadel Advisors (USD 34m).
21 managers in our coverage reported it, and between them they run 280 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Logos Global Management, where the position was 4.1% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with BioNTech SE or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.